Article
Acute myeloid leukemia stem cells: seek and destroy
25 Nov 2009
Abstract excerpt
Most adult patients with acute myeloid leukemia (AML) die from their disease. Relapses are frequent even after aggressive multiagent chemotherapy and allogeneic stem cell transplantation. AML is a biologically heterogeneous disease, characterized by frequent cytogenetic abnormalities and an increasing spectrum of genetic mutations and molecular aberrations. Laboratory data suggest that AML originates from a rare...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
